Term
Six Major Pituitary Hormones |
|
Definition
ACTH, GH, PRL, TSH, LH, FSH |
|
|
Term
|
Definition
PRL consists 198 amino acids molecular mass of 21,500 kDa; similar to GH and hPL. synthesized by lactotropes |
|
|
Term
|
Definition
produce PRL and compromise 20% or anterior pituitary cells. same common precursor as somatotropes which give rise to tumor secreting both PRL and GH. Hyperplasia during lasat two trimesters of pregnancy and few months of lacatation |
|
|
Term
|
Definition
synthesis begins at 12 weeks gestation. normal adult levels are 10 to 25 ug/L in women and 10-20 ug/L in men. pulsatile with highest during REM. Peak between 4-6 a.m. circulating half-life 50min. inhibited by dopamine. glucocorticoid and thyroid hormone suppress PRL secretion. Serum levels rise after cexercise, meals, sex, stress, minor surgical procedures. |
|
|
Term
Inhibitors/Suppressors of Prolactin |
|
Definition
Dopamine inhibits secretion. Glucocorticoids and thyroid hormones suppress PRL secretion. |
|
|
Term
|
Definition
dopamine agonists (levodopa). Pituitary destruction or removal and lymphocytic hypophysitis. |
|
|
Term
Type 1 cytokine receptor family |
|
Definition
|
|
Term
|
Definition
ligand binding leads to receptor dimerization followed by intracellular signaling mediated by JAKII. In breast lactogens, elevated progesterone. PRL induces and maintains lactaion, decreases reproductive function, suppress sexual drive. suppresses hypthalamic GnRH and pituitary gonadotropin secretion in ovary. PRL blocks folliculogenesis leading to hypoestrogenism and anovulation. inhibits spermatogenesis. decrease libido, reduce fertility with heperprolactinemia. brain centers for parenting behavior, appetite stimulation |
|
|
Term
|
Definition
associated with enhanced risk for bone loss and long-term development of osteoporosis. |
|
|
Term
Etiology Hyperprolactinemia |
|
Definition
HPRL most common pituitary hormone hypersecretion syndrome in both males and females. PRL-secreting pituitary adenomas are most common cause of PRL levels>100ug/L. Hypothalamic/Pituitary stalk compression or lesions. chest wall trauma. pituitary tumors. |
|
|
Term
Treatment of Hyperprolactinemia |
|
Definition
depends on cause of elevated PRL levels. dopamine agonists are effective for many different causes of hyperprolactinemia. |
|
|
Term
|
Definition
tumors of lactotrope cells, mixed tumors secreting combinations. tumor size correlates directly with PRL concentrations; 100ug/L associated with macroadenomas |
|
|
Term
|
Definition
less than 1 cm in diameter |
|
|
Term
|
Definition
greater than 1 cm diameter. generally associated with levels 100ug/L |
|
|
Term
Female:Male ratio microprolactinomas |
|
Definition
|
|
Term
Female:Male Macroprolactinomas |
|
Definition
|
|
Term
Woman Clinical Signs and Symptoms of Prolactinoma |
|
Definition
woman usually present with amenorrhea. Infertility. Galactorrhea, if tumor extends outside of the sella, visual field defects. |
|
|
Term
Man Clinical Signs and Symptoms of Prolactinoma |
|
Definition
impotence, loss of libido, infertility, or signs of CNS compression including headaches and visual defects. diagnosis is PRL > 100ug/L. PRL levels <100ug/L may be caused by microadenomas, other sellar lesions that decrease dopamine inhibition, or nonneoplastic causes of hyperprolactinemia. |
|
|